WebbMEDICHEM's shares are to be obtained by contribution of MEDICHEM. Intellectual Property Rights and shall vest automatically according to. APPENDIX E. 4.2 The COMPANY shall be known as SARAWAK MEDICHEM PHARMACEUTICALS, INC.. or such other name as may be approved by the Secretary of State of. Delaware, United States of America. WebbSARAWAK MEDICHEM PHARMACEUTICALS is a trademark owned by Sarawak MediChem Pharmaceuticals and filed on Tuesday, January 19, 1999 in the Pharmaceutical …
SARAWAK MEDICHEM PHARMACEUTICALS Trademark
WebbIn 2002 alone, American pharmaceutical research companies invested US$32 billion in research and development, which represents US$20 billion more than in 1992. Advances in technology and scientific knowledge also allowed significant improvements in the research and development (R&D) process, permitting to screen larger number of samples. Webb27 okt. 2000 · MediChem also engages in a joint venture for drug discovery with the government of Malaysia. The joint venture, Sarawak MediChem Pharmaceuticals, is … tinea cruris vs erythrasma
Sarawak Medichem Pharmaceuticals Inc. - Company Profiles - BCIQ
Webb1995: Calanolides licensed to Medichem Research Inc. Synthesis of (+)-calanolide A supported by NCI SBIR grant Negotiation with Sarawak State Govt. required by LOC … Webb15 maj 2004 · The SARAWAK MEDICHEM PHARMACEUTICALS mark is filed in the category of Pharmaceutical Products . The legal correspondent for SARAWAK MEDICHEM PHARMACEUTICALS trademark is JOHN J. MCDONNELL, MCDONNELL BOEHNEN HULBERT & BERGHOFF, 300 S WACKER DR STE 3200 CHICAGO IL 60606-6705 . WebbSarawak MediChem Pharmaceuticals, a joint venture between the state government and US-based Advanced Life Sciences Inc, is now carrying out early Phase II clinical trials of … tinea cruris what is it